tradingkey.logo

Revvity climbs after forecasting upbeat 2026 profit on diagnostics strength

ReutersFeb 2, 2026 1:24 PM

Shares of medical equipment maker Revvity RVTY.N rise 2% to $111 premarket

Co forecasts 2026 adjusted profit per share of $5.35 to $5.45 vs analysts' average estimate of $5.32 - LSEG data

RVTY reports Q4 adj. profit of $1.70/shr vs estimates of $1.55/shr

Co's quarterly revenue of $772.1 million beats analysts' expectation of $761.3 million

Up to last close, stock down 14.3% in last 12 months

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI